{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-25-004948","form_type":"8-K","ticker":"PHIO","cik":"0001533040","company_name":"Phio Pharmaceuticals Corp.","filed_at":"2025-07-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.250359+00:00","generated_at":"2026-05-18T09:16:11.751073+00:00","sec_items":["8.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Phio sets 2025 annual meeting for Sept 11; new proposal deadlines","bullets":["Annual meeting on Sept 11, 2025; record date July 18, 2025.","Rule 14a-8 stockholder proposals must be received by July 17, 2025.","Director nominations and other proposals not in proxy materials also due July 17, 2025.","Meeting date moved >30 days from 2024 anniversary, triggering revised deadlines."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-25-004948","json":"https://secwatch.observer/filing/0001683168-25-004948.json","markdown":"https://secwatch.observer/filing/0001683168-25-004948.md","text":"https://secwatch.observer/filing/0001683168-25-004948.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533040/000168316825004948/0001683168-25-004948-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533040/000168316825004948/phio_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T09:16:11.751073+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}